Telemedicine Feasible For Large-Scale Use in Epilepsy
December 8th 2019A single-center study of more than 3600 virtual visits displayed a high level of satisfaction from patients regarding their experience with telemedicine and their providers, suggesting the practice may be ready for large-scale use.
Sumeet Vadera, MD: Barriers to Getting Patients to Epilepsy Surgery
December 8th 2019The director of epilepsy surgery and associate professor of neurosurgery at UC Irvine discussed the challenges he has encountered in getting patients with epilepsy to undergo beneficial procedures, often due to misinformation.
Elizabeth Thiele, MD, PhD: GWPCARE6 Trial of CBD in Tuberous Sclerosis Complex
December 8th 2019The director of pediatric epilepsy and the Herscot Center for Tuberous Sclerosis Complex at Massachusetts General Hospital, and professor of neurology at Harvard Medical School discussed the findings of the GWPCARE6 trial of cannabidiol.
Breastfeeding Rates Are Lower Among Women With Epilepsy
December 8th 2019Despite evidence of the benefits and safety of breastfeeding in women with epilepsy, 2 studies suggest this population breastfeeds significantly less often than women without epilepsy, due to fears of drug exposure or recommendations against the practice.
James Wheless, MD: Treating Seizure Clusters With Midazolam
December 8th 2019The professor and chief of pediatric neurology, and director of the comprehensive epilepsy program and neuroscience institute at Le Bonheur Children’s Hospital offered insight into his experience with midazolam and its potential to play a vital role in treating seizure clusters.
Anup Patel, MD: Transmitting Epilepsy Information Correctly
October 23rd 2019The associate professor of clinical pediatrics and neurology at Ohio State University and section chief of pediatric neurology at Nationwide Children’s Hospital stresses the importance of broadcasting correct information to the public concerning epilepsy.
Essential Tremor Symptoms, Severity Improved With Cala Trio Neuromodulation Device
October 22nd 2019The wrist-worn wearable neuromodulation device for essential tremor was shown to be safe and efficacious in the PROSPECT trial, with more than 50% of patients experiencing a ≥50% improvement in tremor "power" or severity.
Marie D'hooghe, MD, PhD: Pregnancy Plans for Patients With MS
October 4th 2019The neurologist at the National MS Center and University Hospital, in Brussels, discussed the clinician mindset when treating women with MS who plan to get pregnant, and how patients using assistive reproductive treatments should be approached.
Mitsubishi Tanabe Reveals Phase 3 Study for Continuous Carbidopa/Levodopa in Parkinson Disease
September 26th 2019The clinical development of ND0612 includes 2 doses; a low dose for mid-stage Parkinson patients experiencing loss of motor control on oral therapy, and a high dose for severe disease in which oral drugs are no longer effective.
Amantadine ER Capsules for Dyskinesia Show Consistent Safety, Improved Motor Skills
September 25th 2019Data of amantadine (Gocovri, Adamas) extended-release tablets suggested that the therapy is, in fact, safe and tolerable with a unique pharmacokinetic profile, and results in significant improvements in dyskinesia for patients with Parkinson disease.